SEC Form D · filed January 21, 2021
Xilio Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Riyaz Nooruddin · GRAND CAYMAN, Cayman IslandsDirectorRobert Weisskoff · Saddle Brook, NJDirectorMatthew Butcher · Longmont, CODirectorJoseph Farmer · Waltham, MAExecJoshua Owen · Raleigh, NCDirectorJeffrey Williams · Raleigh, NCExecScale Venture Capital Management Group LLC · Dover, DEDirectorPaul Clancy · Waltham, MADirectorSrini A. Surendranath · Powell, OHExecPeter Dudek · Waltham, MADirectorSheri C. Jones · Powell, OHExecDaniel Curran · Waltham, MADirectorNancy Hong · Waltham, MADirectorRene Russo · Waltham, MAExec · DirectorRachel Humphrey · Waltham, MADirectorDaniel Lynch · Waltham, MADirectorLeo Backer · SEATTLE, WADirectorMichael Ross · Waltham, MADirectorEvan Edwards · Raleigh, NCExecCarl Sparks · Dallas, TXDirectorMatthew A. Jones · Powell, OHDirectorNancy Hong · Waltham, MADirectorDaniel A. Charna · Powell, OHExec · DirectorJeffrey Williams · Dallas, TXDirectorKevin Mosley · Raleigh, NCExec · DirectorRobert Weisskoff · Berkeley, CADirectorDavid Grayzel · Waltham, MADirectorTimothy Clackson · Waltham, MAExecSerge De Reus · Amsterdam, P7DirectorIvana Faltysova · GRAND CAYMAN, Cayman IslandsDirectorJeff Feinstein · SEATTLE, WADirectorPeter Dudek · Waltham, MADirectorPriyanka Chopra · San Francisco, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗